AUTL
Autolus Therapeutics Ltd
NASDAQ: AUTL · HEALTHCARE · BIOTECHNOLOGY
$1.41
+0.00% today
Updated 2026-04-30
Market cap
$375.26M
P/E ratio
—
P/S ratio
347.95x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$1 – $3
Volume
1.7M
Autolus Therapeutics Ltd (AUTL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.33M | $-9.85M | $-16.36M | $-25.85M | $-25.85M | $-101.48M | $-117.76M | $-117.86M | $-112.31M | $-145.59M | $-206.27M | $-283.57M |
| Capital expenditures | $762065.00 | $1.85M | $2.88M | $8.77M | $8.77M | $18.67M | $14.68M | $8.86M | $10.84M | $10.99M | $34.82M | $19.09M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $2.26M | $3.15M | $5.03M | $5.03M | $30.21M | $20.11M | $9.94M | $12.01M | $11.20M | $15.47M | $14.44M |
| Free cash flow | $-4.09M | $-11.70M | $-19.24M | $-34.62M | $-34.62M | $-120.15M | $-132.44M | $-126.72M | $-123.15M | $-156.57M | $-241.09M | $-302.66M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — |